Protalix Biotherapeutics, Inc. (PLX)

1.99 -0.03 (-1.49%) USD  |  NYAM  |  May 07, 16:00
1.99 0.00 (0.00%) After-Hours: 20:00
More

Protalix Biotherapeutics Research and Development Expense (Annual) : 19.05M for Dec. 31, 2025

Research and Development Expense (Annual) Chart

View Research and Development Expense (Annual) for PLX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Research and Development Expense (Annual) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

R&D Expense Definition

View R&D Expense Definition
Start Trial

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (Annual) Range, Past 5 Years

View Research and Development Expense (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Research and Development Expense (Annual) Benchmarks

View Research and Development Expense (Annual) Benchmarks
Start Trial
Agenus, Inc. 79.34M
Lisata Therapeutics, Inc. 7.949M
InspireMD, Inc. 15.00M
Lifeward Ltd. 3.249M
Denali Therapeutics, Inc. 418.78M